Please provide your email address to receive an email when new articles are posted on . Implicity announced the FDA cleared its algorithm analyzing ECG data from implantable loop recorders.
August 14, 2003 — When evaluating select patients with recurrent unexplained syncope, a diagnostic strategy of prolonged primary monitoring using an implantable loop recorder is more cost effective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback